In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the Indian patient. The pharma industry suffered a body blow recently after government agencies pulled up over 50 popular medicine brands. How do patients trust their medicines?
Related Posts
An army of 12,000 medical reps: How Rajeev Juneja flexed Mankind to the pharma top order
Synopsis While Ramesh Juneja has led Mankind Pharma for three decades, his brother Rajeev kept in tow and took charge…
Heart ailments in young Indians are on a tear. But fixing lifestyle remains an arduous task.
“When I started practice in India about 30 years ago, I would see a person under 30 years or between…
Once dumped by investors, Orchid Pharma blooms in glory with first novel antibiotic drug
Getty Images Synopsis Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. After years of research…
